Ken Griffin’s Elevai Labs ELAB Stock Holding History

Ken Griffin’s Portfolio ELAB Stock Details ELAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-212	Closed	-$38.5K	–	13059
2025 Q2	$38.5K	Buy	+212	New	+$45.9K	﹤0.01%	11895

Other funds holding ELAB

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ken Griffin's ELAB Position: Q3 2025 in Review

Ken Griffin sold out of Elevai Labs (ELAB) in Q3 2025, closing a stake of 212 shares — an estimated $38.5K sold.

Ken Griffin first reported a position in ELAB in Q2 2025 and held it in 1 quarter. The position peaked at $38.5K in Q2 2025. 3 funds tracked by Wall St. Rank hold ELAB as of Q3 2025.

Ken Griffin reported no remaining Elevai Labs position as of Q3 2025 after selling out during the quarter.
Ken Griffin sold 212 Elevai Labs shares in Q3 2025, an estimated $38.5K.
Ken Griffin first reported a position in Elevai Labs in Q2 2025 and held it in 1 quarter.
Ken Griffin's Elevai Labs position peaked at $38.5K in Q2 2025.
3 funds tracked by Wall St. Rank held Elevai Labs as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.